{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:19:06Z","timestamp":1791397146996,"version":"4.3.3"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T00:00:00Z","timestamp":1640044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T00:00:00Z","timestamp":1640044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangzhou science and technology plan projects"},{"name":"Bejing Bethune Chartfable Foundation","award":["SCE111DS"],"award-info":[{"award-number":["SCE111DS"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Nowadays, acute leukemia (AL) among children has favorable outcome, yet some of them get refractory or relapse mainly due to drug resistance. High-mobility group box 1 (HMGB1) has been proven to have a important role in drug resistance via upregulation of autophagy after chemotherapy treatment in acute leukemia. However, the mechanism how extracellular HMGB1 acts on AL cells and leads to chemoresistance remains elusive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>CCK8 was used to examine the toxicity of chemotherapeutic drug. Elisa was performed to detect the release of HMGB1. Western blot and mRFP-GFP-LC3 adenoviral particles as well as transmission electron microscopy were used to detect the autophagy flux. Western blot and flow cytometry were applied to evaluate the apoptosis. qPCR and western blot were conducted to detect the expression of drug efflux protein. Lentivirus infection was applied to knock down RAGE. In addition, T-ALL NOD\/SCID mice xenograft model was used to observe the effect of inhibiting HMGB1\/RAGE axis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found that extracellular HMGB1 do upregulate autophagy and in the meantime downregulate apoptosis, primarily through interaction with receptor for advanced glycation end products (RAGE). Suppression of RAGE by RNA interference alleviated the level of autophagy and enhanced apoptosis. What\u2019s more, HMGB1\/RAGE induced autophagy was associated with the activation of ERK1\/2 and decreased phosphorylation of mammalian target of rapamycin (mTOR), while HMGB1\/RAGE limited apoptosis in a Bcl-2-regulated way mediated by P53. On the other hand, we found that HMGB1\/RAGE activated the NF-\u03baB pathway and promoted the expression of P-glycation protein (P-gp) as well as multidrug resistance-associated protein (MRP), both are ATP-binding cassette transporters. In vivo experiment, we found that blocking HMGB1\/RAGE axis do have a mild pathological condition and a better survival in T-ALL mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HMGB1\/RAGE have a important role in drug resistance after chemotherapy treatment, mainly by regulating autophagy and apoptosis as well as promoting the expression of drug efflux protein such as P-gp and MRP. HMGB1\/RAGE might be a promising target to cure AL, especially for those met with relapse and refractory.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12935-021-02387-9","type":"journal-article","created":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T12:03:07Z","timestamp":1640088187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Extracellular HMGB1 interacts with RAGE and promotes chemoresistance in acute leukemia cells"],"prefix":"10.1186","volume":"21","author":[{"given":"Weixin","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5389-797X","authenticated-orcid":false,"given":"Jianpei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,21]]},"reference":[{"issue":"9","key":"2387_CR1","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s12098-015-1695-5","volume":"82","author":"R Seth","year":"2015","unstructured":"Seth R, Singh A. Leukemias in children. Indian J Pediatr. 2015;82(9):817\u201324.","journal-title":"Indian J Pediatr"},{"issue":"2","key":"2387_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/gcc.22416","volume":"56","author":"K Karrman","year":"2017","unstructured":"Karrman K, Johansson B. Pediatric T-cell acute lymphoblastic leukemia. Genes Chromosom Cancer. 2017;56(2):89\u2013116.","journal-title":"Genes Chromosom Cancer"},{"issue":"1","key":"2387_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/14737140.2021.1841640","volume":"21","author":"AE Hoffman","year":"2021","unstructured":"Hoffman AE, Schoonmade LJ, Kaspers GJ. Pediatric relapsed acute myeloid leukemia: a systematic review. Expert Rev Anticancer Ther. 2021;21(1):45\u201352.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"4","key":"2387_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/hon.2541","volume":"36","author":"S Shen","year":"2018","unstructured":"Shen S, Cai J, Chen J, et al. Long-term results of the risk-stratified treatment of childhood acute lymphoblastic leukemia in China. Hematol Oncol. 2018;36(4):679\u201388.","journal-title":"Hematol Oncol"},{"issue":"14","key":"2387_CR5","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","volume":"30","author":"SP Hunger","year":"2012","unstructured":"Hunger SP, Lu X, Devidas M, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the Children\u2019s Oncology Group. J Clin Oncol. 2012;30(14):1663\u20139.","journal-title":"J Clin Oncol"},{"key":"2387_CR6","doi-asserted-by":"publisher","first-page":"100646","DOI":"10.1016\/j.drup.2019.100646","volume":"47","author":"AB Sarmento-Ribeiro","year":"2019","unstructured":"Sarmento-Ribeiro AB, Scorilas A, Gon\u00e7alves AC, et al. The emergence of drug resistance to targeted cancer therapies: clinical evidence. Drug Resist Updates. 2019;47:100646.","journal-title":"Drug Resist Updates"},{"issue":"3","key":"2387_CR7","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/leu.2014.349","volume":"29","author":"AR Sehgal","year":"2015","unstructured":"Sehgal AR, Konig H, Johnson DE, et al. You eat what you are: autophagy inhibition as a therapeutic strategy in leukemia. Leukemia. 2015;29(3):517\u201325.","journal-title":"Leukemia"},{"issue":"2","key":"2387_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jons.2017.07.001","volume":"3","author":"ON Sever","year":"2017","unstructured":"Sever ON, Demir OG. Autophagy: cell death or survive mechanism. J Oncol Sci. 2017;3(2):37\u201344.","journal-title":"J Oncol Sci"},{"issue":"7","key":"2387_CR9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.leukres.2003.10.032","volume":"28","author":"D Schuler","year":"2004","unstructured":"Schuler D, Szende B. Apoptosis in acute leukemia. Leuk Res. 2004;28(7):661\u20136.","journal-title":"Leuk Res"},{"issue":"5","key":"2387_CR10","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"1","key":"2387_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bbamcr.2014.09.023","volume":"1853","author":"C Evangelisti","year":"2015","unstructured":"Evangelisti C, Evangelisti C, Chiarini F, et al. Autophagy in acute leukemias: A double-edged sword with important therapeutic implications. Biochim Biophys Acta BBA Mol Cell Res. 2015;1853(1):14\u201326.","journal-title":"Biochim Biophys Acta BBA Mol Cell Res"},{"issue":"12","key":"2387_CR12","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1016\/j.bbamcr.2013.06.001","volume":"1833","author":"V Nikoletopoulou","year":"2013","unstructured":"Nikoletopoulou V, Markaki M, Palikaras K, et al. Crosstalk between apoptosis, necrosis and autophagy. Biochim Biophys Acta BBA Mol Cell Res. 2013;1833(12):3448\u201359.","journal-title":"Biochim Biophys Acta BBA Mol Cell Res"},{"issue":"23","key":"2387_CR13","doi-asserted-by":"publisher","first-page":"8991","DOI":"10.3390\/ijms21238991","volume":"21","author":"J Xu","year":"2020","unstructured":"Xu J, Patel NH, Gewirtz DA. Triangular relationship between p53, autophagy, and chemotherapy resistance. Int J Mol Sci. 2020;21(23):8991.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2387_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3109\/10428194.2011.616962","volume":"53","author":"L Yang","year":"2012","unstructured":"Yang L, Yu Y, Kang R, et al. Up-regulated autophagy by endogenous high mobility group box-1 promotes chemoresistance in leukemia cells. Leuk Lymphoma. 2012;53(2):315\u201322.","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"2387_CR15","doi-asserted-by":"publisher","first-page":"601","DOI":"10.5483\/BMBRep.2011.44.9.601","volume":"44","author":"M Zhao","year":"2011","unstructured":"Zhao M, Yang M, Yang L, et al. HMGB1 regulates autophagy through increasing transcriptional activities of JNK and ERK in human myeloid leukemia cells. BMB Rep. 2011;44(9):601\u20136.","journal-title":"BMB Rep"},{"issue":"1","key":"2387_CR16","doi-asserted-by":"publisher","first-page":"12807","DOI":"10.1038\/srep12807","volume":"5","author":"Z Huang","year":"2015","unstructured":"Huang Z, Zhong Z, Zhang L, et al. Down-regulation of HMGB1 expression by shRNA constructs inhibits the bioactivity of urothelial carcinoma cell lines via the NF-\u03baB pathway. Sci Rep. 2015;5(1):12807.","journal-title":"Sci Rep"},{"key":"2387_CR17","doi-asserted-by":"publisher","first-page":"108714","DOI":"10.1016\/j.biopha.2019.108714","volume":"112","author":"Y Liu","year":"2019","unstructured":"Liu Y, Chen P, Xu L, et al. Extracellular HMGB1 prevents necroptosis in acute myeloid leukemia cells. Biomed Pharmacother. 2019;112:108714.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"2387_CR18","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/s41419-018-1019-6","volume":"9","author":"C Huang","year":"2018","unstructured":"Huang C, Chiang S, Chen WT, et al. HMGB1 promotes ERK-mediated mitochondrial Drp1 phosphorylation for chemoresistance through RAGE in colorectal cancer. Cell Death Dis. 2018;9(10):1004.","journal-title":"Cell Death Dis"},{"issue":"42","key":"2387_CR19","doi-asserted-by":"publisher","first-page":"71642","DOI":"10.18632\/oncotarget.17796","volume":"8","author":"H Yin","year":"2017","unstructured":"Yin H, Yang X, Gu W, et al. HMGB1-mediated autophagy attenuates gemcitabine-induced apoptosis in bladder cancer cells involving JNK and ERK activation. Oncotarget. 2017;8(42):71642\u201356.","journal-title":"Oncotarget"},{"issue":"1","key":"2387_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-020-00920-3","volume":"13","author":"S Yuan","year":"2020","unstructured":"Yuan S, Liu Z, Xu Z, et al. High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies. J Hematol Oncol. 2020;13(1):1\u201391.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"2387_CR21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4103\/1110-1067.161290","volume":"40","author":"M Farahat","year":"2015","unstructured":"Farahat M, Sharaf M, Attia T. The serum high-mobility group box 1 level and RAGE expression in childhood acute lymphoblastic leukemic patients\u2019. Egypt J Haematol. 2015;40(2):60.","journal-title":"Egypt J Haematol"},{"issue":"1","key":"2387_CR22","first-page":"368","volume":"19","author":"Y Li","year":"2020","unstructured":"Li Y, Xie J, Li X, et al. Poly (ADP-ribosylation) of HMGB1 facilitates its acetylation and promotes HMGB1 translocation-associated chemotherapy-induced autophagy in leukaemia cells. Oncol Lett. 2020;19(1):368\u201378.","journal-title":"Oncol Lett"},{"issue":"8","key":"2387_CR23","doi-asserted-by":"publisher","first-page":"904","DOI":"10.4161\/auto.7.8.15704","volume":"7","author":"R Kang","year":"2011","unstructured":"Kang R, Livesey KM, Zeh HR, et al. HMGB1 as an autophagy sensor in oxidative stress. Autophagy. 2011;7(8):904\u20136.","journal-title":"Autophagy"},{"issue":"1","key":"2387_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3892\/ijo.2015.2985","volume":"47","author":"Q Kong","year":"2015","unstructured":"Kong Q, Xu L, Xu W, et al. HMGB1 translocation is involved in the transformation of autophagy complexes and promotes chemoresistance in leukaemia. Int J Oncol. 2015;47(1):161\u201370.","journal-title":"Int J Oncol"},{"key":"2387_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.smim.2018.02.011","volume":"38","author":"U Andersson","year":"2018","unstructured":"Andersson U, Yang H, Harris H. High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells. Semin Immunol. 2018;38:40\u20138.","journal-title":"Semin Immunol"},{"issue":"38","key":"2387_CR26","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.1038\/onc.2010.261","volume":"29","author":"D Tang","year":"2010","unstructured":"Tang D, Kang R, Cheh CW, et al. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene. 2010;29(38):5299\u2013310.","journal-title":"Oncogene"},{"issue":"6","key":"2387_CR27","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1080\/10409238.2020.1819194","volume":"55","author":"N Jangde","year":"2020","unstructured":"Jangde N, Ray R, Rai V. RAGE and its ligands: from pathogenesis to therapeutics. Crit Rev Biochem Mol Biol. 2020;55(6):555\u201375.","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"7","key":"2387_CR28","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00018-002-8491-x","volume":"59","author":"LG Bucciarelli","year":"2002","unstructured":"Bucciarelli LG, Wendt T, Rong L, et al. RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell Mol Life Sci. 2002;59(7):1117\u201328.","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"2387_CR29","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.3390\/ijms21103613","volume":"21","author":"AH El-Far","year":"2020","unstructured":"El-Far AH, Sroga G, Al Jaouni SK, et al. Role and mechanisms of RAGE-ligand complexes and RAGE-inhibitors in cancer progression. Int J Mol Sci. 2020;21(10):3613.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2387_CR30","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1089\/ars.2010.3378","volume":"15","author":"R Kang","year":"2011","unstructured":"Kang R, Tang D, Livesey KM, et al. The receptor for advanced glycation end-products (RAGE) protects pancreatic tumor cells against oxidative injury. Antioxid Redox Signal. 2011;15(8):2175\u201384.","journal-title":"Antioxid Redox Signal"},{"issue":"8","key":"2387_CR31","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1007\/s10350-006-0850-5","volume":"50","author":"MK Fuentes","year":"2007","unstructured":"Fuentes MK, Nigavekar SS, Arumugam T, et al. RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways. Dis Colon Rectum. 2007;50(8):1230\u201340.","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"2387_CR32","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/cdd.2009.149","volume":"17","author":"R Kang","year":"2010","unstructured":"Kang R, Tang D, Schapiro NE, et al. The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. Cell Death Differ. 2010;17(4):666\u201376.","journal-title":"Cell Death Differ"},{"issue":"11","key":"2387_CR33","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1007\/s00109-005-0688-7","volume":"83","author":"A Bierhaus","year":"2005","unstructured":"Bierhaus A, Humpert PM, Morcos M, et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med. 2005;83(11):876\u201386.","journal-title":"J Mol Med"},{"issue":"2","key":"2387_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrc2789","volume":"10","author":"JI Fletcher","year":"2010","unstructured":"Fletcher JI, Haber M, Henderson MJ, et al. ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer. 2010;10(2):147\u201356.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2387_CR35","first-page":"87","volume":"30","author":"N Fazlina","year":"2008","unstructured":"Fazlina N, Maha A, Zarina AL, et al. Assessment of P-gp and MRP1 activities using MultiDrugQuant Assay Kit: a preliminary study of correlation between protein expressions and its functional activities in newly diagnosed acute leukaemia patients. Malays J Pathol. 2008;30(2):87\u201393.","journal-title":"Malays J Pathol"},{"issue":"20","key":"2387_CR36","doi-asserted-by":"publisher","first-page":"5062","DOI":"10.1182\/bloodadvances.2020001576","volume":"4","author":"E Morrish","year":"2020","unstructured":"Morrish E, Copeland A, Moujalled DM, et al. Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML models. Blood Adv. 2020;4(20):5062\u201377.","journal-title":"Blood Adv"},{"issue":"3","key":"2387_CR37","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1182\/blood.V94.3.1046.415k03_1046_1056","volume":"94","author":"O Legrand","year":"1999","unstructured":"Legrand O, Simonin G, Beauchamp-Nicoud A, et al. Simultaneous activity of MRP1 and Pgp is correlated with in vitro resistance to daunorubicin and with in vivo resistance in adult acute myeloid leukemia. Blood. 1999;94(3):1046\u201356.","journal-title":"Blood"},{"issue":"4","key":"2387_CR38","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3892\/mmr.2014.1961","volume":"9","author":"Y Yin","year":"2014","unstructured":"Yin Y, Li W, Deng M, et al. Extracellular high mobility group box chromosomal protein 1 promotes drug resistance by increasing the expression of P-glycoprotein expression in gastric adenocarcinoma cells. Mol Med Rep. 2014;9(4):1439\u201343.","journal-title":"Mol Med Rep"},{"issue":"8","key":"2387_CR39","doi-asserted-by":"publisher","first-page":"e71071","DOI":"10.1371\/journal.pone.0071071","volume":"8","author":"BX Zhao","year":"2013","unstructured":"Zhao BX, Sun YB, Wang SQ, et al. Grape seed procyanidin reversal of p-glycoprotein associated multi-drug resistance via down-regulation of NF-kappaB and MAPK\/ERK mediated YB-1 activity in A2780\/T cells. PLoS ONE. 2013;8(8):e71071.","journal-title":"PLoS ONE"},{"issue":"1","key":"2387_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CAD.0000000000000572","volume":"29","author":"C Chen","year":"2018","unstructured":"Chen C, Lu L, Yan S, et al. Autophagy and doxorubicin resistance in cancer. Anticancer Drugs. 2018;29(1):1\u20139.","journal-title":"Anticancer Drugs"},{"issue":"16","key":"2387_CR41","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1093\/emboj\/20.16.4337","volume":"20","author":"S Muller","year":"2001","unstructured":"Muller S, Scaffidi P, Degryse B, et al. New EMBO members\u2019 review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal. EMBO J. 2001;20(16):4337\u201340.","journal-title":"EMBO J"},{"issue":"12","key":"2387_CR42","doi-asserted-by":"publisher","first-page":"e28491","DOI":"10.1371\/journal.pone.0028491","volume":"6","author":"W Han","year":"2011","unstructured":"Han W, Sun J, Feng L, et al. Autophagy inhibition enhances daunorubicin-induced apoptosis in K562 cells. PLoS ONE. 2011;6(12):e28491.","journal-title":"PLoS ONE"},{"issue":"43","key":"2387_CR43","doi-asserted-by":"publisher","first-page":"25752","DOI":"10.1074\/jbc.270.43.25752","volume":"270","author":"O Hori","year":"1995","unstructured":"Hori O, Brett J, Slattery T, et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. J Biol Chem. 1995;270(43):25752.","journal-title":"J Biol Chem"},{"issue":"13","key":"2387_CR44","doi-asserted-by":"publisher","first-page":"5628","DOI":"10.1158\/0008-5472.CAN-10-0595","volume":"70","author":"AZ Kalea","year":"2010","unstructured":"Kalea AZ, See F, Harja E, et al. Alternatively spliced RAGEv1 inhibits tumorigenesis through suppression of JNK signaling. Cancer Res. 2010;70(13):5628\u201338.","journal-title":"Cancer Res"},{"issue":"2","key":"2387_CR45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/path.2391","volume":"216","author":"D Wu","year":"2008","unstructured":"Wu D, Ding Y, Wang S, et al. Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma. J Pathol. 2008;216(2):167\u201375.","journal-title":"J Pathol"},{"issue":"6","key":"2387_CR46","doi-asserted-by":"publisher","first-page":"989","DOI":"10.4161\/auto.20258","volume":"8","author":"R Kang","year":"2012","unstructured":"Kang R, Tang D, Lotze MT, et al. AGER\/RAGE-mediated autophagy promotes pancreatic tumorigenesis and bioenergetics through the IL6-pSTAT3 pathway. Autophagy. 2012;8(6):989\u201391.","journal-title":"Autophagy"},{"issue":"10","key":"2387_CR47","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.4161\/auto.7.10.16753","volume":"7","author":"R Kang","year":"2011","unstructured":"Kang R, Livesey KM, Zeh IHJ, et al. Metabolic regulation by HMGB1-mediated autophagy and mitophagy. Autophagy. 2011;7(10):1256\u20138.","journal-title":"Autophagy"},{"key":"2387_CR48","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/1476-4598-13-165","volume":"13","author":"B Pan","year":"2014","unstructured":"Pan B, Chen D, Huang J, et al. HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma. Mol Cancer. 2014;13:165.","journal-title":"Mol Cancer"},{"issue":"38","key":"2387_CR49","doi-asserted-by":"publisher","first-page":"63290","DOI":"10.18632\/oncotarget.18796","volume":"8","author":"J Li","year":"2017","unstructured":"Li J, Sun J, Rong R, et al. HMGB1 promotes myeloid-derived suppressor cells and renal cell carcinoma immune escape. Oncotarget. 2017;8(38):63290\u20138.","journal-title":"Oncotarget"},{"issue":"10","key":"2387_CR50","first-page":"1016","volume":"41","author":"L Liu","year":"2016","unstructured":"Liu L, Gao F, Ye Y, et al. Influence of HMGB1\/MAPK\/m-TOR signaling pathway on cell autophagy and chemotherapy resistance in K562 cells. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2016;41(10):1016\u201323.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"8","key":"2387_CR51","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1158\/0008-5472.CAN-11-2291","volume":"72","author":"KM Livesey","year":"2012","unstructured":"Livesey KM, Kang R, Vernon P, et al. p53\/HMGB1 complexes regulate autophagy and apoptosis. Canver Res. 2012;72(8):1996\u20132005.","journal-title":"Canver Res"},{"issue":"1","key":"2387_CR52","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/cdd.2017.169","volume":"25","author":"BJ Aubrey","year":"2018","unstructured":"Aubrey BJ, Kelly GL, Janic A, et al. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death Differ. 2018;25(1):104\u201313.","journal-title":"Cell Death Differ"},{"key":"2387_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2014.05.001","volume":"40","author":"R Kang","year":"2014","unstructured":"Kang R, Chen R, Zhang Q, et al. HMGB1 in health and disease. Mol Aspects Med. 2014;40:1\u2013116.","journal-title":"Mol Aspects Med"},{"issue":"6","key":"2387_CR54","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1096\/fj.08-117739","volume":"23","author":"AZ Kalea","year":"2009","unstructured":"Kalea AZ, Reiniger N, Yang H, et al. Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene. FASEB J. 2009;23(6):1766\u201374.","journal-title":"FASEB J"},{"issue":"11","key":"2387_CR55","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.cellsig.2013.06.013","volume":"25","author":"J Xie","year":"2013","unstructured":"Xie J, M\u00e9ndez JD, M\u00e9ndez-Valenzuela V, et al. Cellular signalling of the receptor for advanced glycation end products (RAGE). Cell Signal. 2013;25(11):2185\u201397.","journal-title":"Cell Signal"},{"issue":"2","key":"2387_CR56","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.blre.2016.10.001","volume":"31","author":"L Yu","year":"2017","unstructured":"Yu L, Li L, Medeiros LJ, et al. NF-\u03baB signaling pathway and its potential as a target for therapy in lymphoid neoplasms. Blood Rev. 2017;31(2):77\u201392.","journal-title":"Blood Rev"},{"issue":"10","key":"2387_CR57","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nri1703","volume":"5","author":"M Karin","year":"2005","unstructured":"Karin M, Greten FR. NF-\u03baB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5(10):749\u201359.","journal-title":"Nat Rev Immunol"},{"key":"2387_CR58","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/bs.acr.2014.10.006","volume":"125","author":"Y Fukuda","year":"2015","unstructured":"Fukuda Y, Lian S, Schuetz JD. Leukemia and ABC transporters. Adv Cancer Res. 2015;125:171\u201396.","journal-title":"Adv Cancer Res"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-021-02387-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-021-02387-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-021-02387-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T16:08:05Z","timestamp":1676131685000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-021-02387-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,21]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2387"],"URL":"https:\/\/doi.org\/10.1186\/s12935-021-02387-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-349396\/v1","asserted-by":"object"}]},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,21]]},"assertion":[{"value":"20 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors involved in the authorship are consent for publication in the current form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"700"}}